caffeine has been researched along with Depression, Endogenous in 59 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinical depression was defined as self-reported physician-diagnosed depression and antidepressant use." | 5.37 | Coffee, caffeine, and risk of depression among women. ( Ascherio, A; Koenen, K; Lucas, M; Mirzaei, F; O'Reilly, ÉJ; Okereke, OI; Pan, A; Willett, WC, 2011) |
| "The reviewed studies support the use of methylphenidate to improve end-of-life patient cognitive functions, particularly in the case of hypoactive delirium." | 4.86 | [Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: A literature review]. ( Elie, D; Gagnon, B; Gagnon, P; Giguère, A, 2010) |
| " CUS-exposed rats showed depressive-like behavior with reduced weight gain, reduced consumption of sucrose solution, increased immobility in the forced swimming test, and hypolocomotion in an open field." | 3.78 | Effect of long-term caffeine administration on depressive-like behavior in rats exposed to chronic unpredictable stress. ( Alova, LH; Nikolov, RP; Pechlivanova, DM; Petkov, VV; Tchekalarova, JD; Yakimova, KS, 2012) |
| "Caffeine increases anxiety in people with anxiety disorders." | 3.67 | Anxiogenic effects of caffeine on panic and depressed patients. ( Cameron, OG; Flegel, P; Greden, JF; Lee, MA, 1988) |
| "Caffeine is an antagonist of adenosine receptors and may enhance antidepressant effects through downstream dopaminergic targets." | 3.01 | Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation. ( Bodén, R; Frick, A; Persson, J, 2021) |
| "Caffeine is a central nervous system stimulant that has come under increasing scrutiny due to its effects on the health and mental health of those who consume it." | 2.37 | Caffeine: implications of recent research for clinical practice. ( Wells, SJ, 1984) |
| "Depression and PTSD were assessed using the Beck Depression Inventory and Clinician-Administered PTSD Scale, respectively." | 1.40 | Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress. ( Baker, DG; Geyer, MA; Minassian, A; Nievergelt, CM; O'Connor, DT; Risbrough, VB, 2014) |
| "Clinical depression was defined as self-reported physician-diagnosed depression and antidepressant use." | 1.37 | Coffee, caffeine, and risk of depression among women. ( Ascherio, A; Koenen, K; Lucas, M; Mirzaei, F; O'Reilly, ÉJ; Okereke, OI; Pan, A; Willett, WC, 2011) |
| "Caffeine (10 mg/kg) pretreatment with venlfaxine (5 mg/kg) did not produce any significant effect on locomotor activity, immobility period and oxidative damage as compared to their effect per se." | 1.36 | Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice. ( Garg, R; Gaur, V; Kumar, A; Kumar, P, 2010) |
| "To determine if excessive daytime sleepiness (EDS) can predate future Parkinson disease (PD)." | 1.33 | Excessive daytime sleepiness and subsequent development of Parkinson disease. ( Abbott, RD; Curb, JD; Masaki, KH; Nelson, JS; Petrovitch, H; Ross, GW; Tanner, CM; White, LR, 2005) |
| " We conclude from this study that caffeine-augmented ECT is safe and effective in increasing seizure duration in the elderly." | 1.29 | Safety and efficacy of caffeine-augmented ECT in elderly depressives: a retrospective study. ( Grossberg, GT; Kelsey, MC, 1995) |
| "Caffeine treatment at the dose 10 mg/kg b." | 1.28 | Validation of aversion towards open space and height as a measure of anxiety in the genetically based animal model of depression. ( Golda, V; Petr, R, 1990) |
| "The caffeine-modified ECT treatments were well tolerated and were associated with no clinically significant adverse cardiovascular effects." | 1.28 | Caffeine-modified electroconvulsive therapy in depressed patients with medical illness. ( Coffey, CE; Lurie, SN, 1990) |
| "The association of three subtypes of insomnia with psychic and functional syndromes, and the course of insomnia over 7 years were examined in a Swiss cohort of young adults interviewed three times." | 1.28 | The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia. ( Angst, J; Vollrath, M; Wicki, W, 1989) |
| "Acute caffeine administration increases cortisol and converts the dexamethasone suppression test (DST) to nonsuppression in normal humans; data concerning chronic administration as well as effects in depressed patients are minimal." | 1.27 | Chronic caffeine consumption and the dexamethasone suppression test in depression. ( Cameron, OG; Flegel, P; Greden, JF; Lee, MA, 1988) |
| "Caffeine was well tolerated, even in patients with cardiovascular diseases." | 1.27 | Use of caffeine to lengthen seizures in ECT. ( Christison, C; Coffey, CE; Cress, M; Hinkle, PE; Weiner, RD, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (33.90) | 18.7374 |
| 1990's | 18 (30.51) | 18.2507 |
| 2000's | 5 (8.47) | 29.6817 |
| 2010's | 15 (25.42) | 24.3611 |
| 2020's | 1 (1.69) | 2.80 |
| Authors | Studies |
|---|---|
| Frick, A | 1 |
| Persson, J | 1 |
| Bodén, R | 1 |
| Jamal, F | 1 |
| Durgam, A | 1 |
| Aickareth, G | 1 |
| Bajaj, R | 1 |
| Mathews, M | 1 |
| Jain, S | 1 |
| Srivastava, AS | 1 |
| Maggu, G | 1 |
| Verma, RP | 1 |
| Smith, AP | 1 |
| Richards, G | 2 |
| Nelson, ST | 1 |
| Hsiao, L | 1 |
| Turgeon, SM | 1 |
| Minassian, A | 1 |
| Geyer, MA | 1 |
| Baker, DG | 1 |
| Nievergelt, CM | 1 |
| O'Connor, DT | 1 |
| Risbrough, VB | 1 |
| Minor, TR | 1 |
| Hanff, TC | 1 |
| Smith, A | 1 |
| Schwartzhaupt, AW | 1 |
| Lara, DR | 1 |
| Hirakata, VN | 1 |
| Schuch, A | 1 |
| Almeida, E | 1 |
| Silveira, L | 1 |
| Caldieraro, MA | 1 |
| Fleck, MP | 1 |
| Kumar, A | 1 |
| Garg, R | 1 |
| Gaur, V | 1 |
| Kumar, P | 1 |
| Pechlivanova, D | 1 |
| Tchekalarova, J | 1 |
| Nikolov, R | 1 |
| Yakimova, K | 1 |
| Ruusunen, A | 1 |
| Lehto, SM | 1 |
| Tolmunen, T | 1 |
| Mursu, J | 1 |
| Kaplan, GA | 1 |
| Voutilainen, S | 1 |
| Elie, D | 1 |
| Gagnon, P | 1 |
| Gagnon, B | 1 |
| Giguère, A | 1 |
| Lucas, M | 1 |
| Mirzaei, F | 1 |
| Pan, A | 1 |
| Okereke, OI | 1 |
| Willett, WC | 1 |
| O'Reilly, ÉJ | 1 |
| Koenen, K | 1 |
| Ascherio, A | 1 |
| Berkowitz, SA | 1 |
| Lapane, KL | 1 |
| Cooke, ME | 1 |
| Pechlivanova, DM | 1 |
| Tchekalarova, JD | 1 |
| Alova, LH | 1 |
| Petkov, VV | 1 |
| Nikolov, RP | 1 |
| Yakimova, KS | 1 |
| Künzel, HE | 1 |
| Binder, EB | 1 |
| Nickel, T | 1 |
| Ising, M | 1 |
| Fuchs, B | 1 |
| Majer, M | 1 |
| Pfennig, A | 1 |
| Ernst, G | 1 |
| Kern, N | 1 |
| Schmid, DA | 1 |
| Uhr, M | 1 |
| Holsboer, F | 1 |
| Modell, S | 1 |
| Kaster, MP | 1 |
| Rosa, AO | 1 |
| Rosso, MM | 1 |
| Goulart, EC | 1 |
| Santos, AR | 1 |
| Rodrigues, AL | 1 |
| Abbott, RD | 1 |
| Ross, GW | 1 |
| White, LR | 1 |
| Tanner, CM | 1 |
| Masaki, KH | 1 |
| Nelson, JS | 1 |
| Curb, JD | 1 |
| Petrovitch, H | 1 |
| Uzbay, TI | 1 |
| Kayir, H | 1 |
| Ceyhan, M | 1 |
| Lake, CR | 1 |
| Quirk, RS | 1 |
| Sattin, A | 1 |
| Wells, SJ | 1 |
| Boulenger, JP | 1 |
| Uhde, TW | 3 |
| Wolff, EA | 1 |
| Post, RM | 2 |
| Kelsey, MC | 1 |
| Grossberg, GT | 1 |
| Beale, MD | 1 |
| Pritchett, JT | 1 |
| Kellner, CH | 2 |
| McCall, WV | 2 |
| Francis, A | 1 |
| Fochtmann, L | 1 |
| Petrides, G | 1 |
| Tancer, ME | 1 |
| Wenokur, B | 1 |
| Lessem, P | 1 |
| Reid, S | 1 |
| Rosenquist, P | 1 |
| Foreman, A | 1 |
| Kiesow-Webb, N | 1 |
| Leibenluft, E | 1 |
| Fiero, PL | 1 |
| Bartko, JJ | 1 |
| Moul, DE | 1 |
| Rosenthal, NE | 1 |
| Mayo, KM | 1 |
| Falkowski, W | 1 |
| Jones, CA | 1 |
| Pomerleau, CS | 1 |
| Aubin, HJ | 1 |
| Pomerleau, OF | 1 |
| Gilbert, DG | 1 |
| McClernon, FJ | 1 |
| Rabinovich, NE | 1 |
| Dibb, WD | 1 |
| Plath, LC | 1 |
| Hiyane, S | 1 |
| Jensen, RA | 1 |
| Meliska, CJ | 1 |
| Estes, SL | 1 |
| Gehlbach, BA | 1 |
| Ancill, RJ | 1 |
| Carlyle, W | 1 |
| Jaffe, R | 1 |
| Dubin, WR | 1 |
| Bachman, DL | 1 |
| Christensen, L | 1 |
| Bourgeois, A | 1 |
| Cockroft, R | 1 |
| Golda, V | 1 |
| Petr, R | 1 |
| Coffey, CE | 4 |
| Figiel, GS | 1 |
| Weiner, RD | 3 |
| Saunders, WB | 1 |
| Lurie, SN | 1 |
| Swartz, CM | 1 |
| Breen, K | 1 |
| Wahby, VS | 1 |
| Burket, RC | 1 |
| Hodgin, JD | 1 |
| Vollrath, M | 1 |
| Wicki, W | 1 |
| Angst, J | 1 |
| Breier, A | 2 |
| Charney, DS | 2 |
| Heninger, GR | 2 |
| Acevedo, AG | 1 |
| Smith, JK | 1 |
| Lee, MA | 2 |
| Flegel, P | 2 |
| Greden, JF | 2 |
| Cameron, OG | 2 |
| Lerer, B | 2 |
| Shapira, B | 2 |
| Drexler, H | 2 |
| Calev, A | 2 |
| Newman, ME | 1 |
| Hinkle, PE | 2 |
| Cress, M | 2 |
| Daughtry, G | 1 |
| Wilson, WH | 1 |
| Christison, C | 1 |
| Gilboa, D | 1 |
| Kugelmass, S | 1 |
| Bruce, M | 1 |
| Bierer, LM | 1 |
| Vittone, BJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Consumption of Energy Drinks on Hemodynamics, Blood Glucose, Short Term Memory, Vigilance and Perception in Healthy Adults[NCT04961086] | 76 participants (Actual) | Interventional | 2021-06-29 | Completed | |||
| Cereset Research To Reduce Stress In Healthcare Workers In The Time Of COVID-19[NCT04682197] | 144 participants (Actual) | Interventional | 2021-12-14 | Active, not recruiting | |||
| Cereset Research for Dementia Caregivers: A Randomized, Placebo-Controlled Trial[NCT05209438] | 20 participants (Anticipated) | Interventional | 2022-06-16 | Recruiting | |||
| Randomized Controlled Pilot Trial of Cereset Research For Chronic Nausea[NCT05229107] | 24 participants (Anticipated) | Interventional | 2024-01-31 | Not yet recruiting | |||
| Cereset Research Exploratory Study[NCT03777267] | 150 participants (Anticipated) | Interventional | 2019-04-12 | Recruiting | |||
| Association Between Adenosine Receptor Gene Polymorphisms and Physiological Responses to Caffeine in Subjects With Panic Disorder and Healthy Controls[NCT00083265] | 117 participants (Actual) | Observational | 2004-05-13 | Completed | |||
| The Impact of Caffeine on Cognition in Schizophrenia[NCT02832401] | 24 participants (Actual) | Interventional | 2016-09-02 | Completed | |||
| Behavioral Therapy for Reduction in Smoking Craving[NCT00449293] | 40 participants (Actual) | Interventional | 2006-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for caffeine and Depression, Endogenous
| Article | Year |
|---|---|
[Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: A literature review].
Topics: Aged; Caffeine; Central Nervous System Stimulants; Cognition Disorders; Confusion; Delirium; Depress | 2010 |
Adenosine receptors: some behavioral implications for depression and sleep.
Topics: Animals; Antidepressive Agents, Tricyclic; Brain; Caffeine; Cerebral Cortex; Cyclic AMP; Depressive | 1984 |
Caffeine: implications of recent research for clinical practice.
Topics: Abnormalities, Drug-Induced; Affective Symptoms; Animals; Blood Pressure; Brain; Caffeine; Child; De | 1984 |
The diagnostic validity of anxiety disorders and their relationship to depressive illness.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Caffeine; Clonidine; | 1985 |
Differential diagnosis and treatment of panic disorder: a medical model perspective.
Topics: Agoraphobia; Antidepressive Agents; Anxiety Disorders; Behavior Therapy; Benzodiazepines; Caffeine; | 1985 |
7 trials available for caffeine and Depression, Endogenous
| Article | Year |
|---|---|
Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation.
Topics: Adolescent; Adult; Caffeine; Coffee; Combined Modality Therapy; Depressive Disorder; Double-Blind Me | 2021 |
Does caffeine change the effect of sleep deprivation on moderate to severe depressed patients?
Topics: Adult; Ambulatory Care; Caffeine; Circadian Rhythm; Complementary Therapies; Cross-Over Studies; Dep | 2009 |
Caffeine: use and effects in long-stay psychiatric patients.
Topics: Adult; Aged; Anxiety Disorders; Caffeine; Depressive Disorder; Dose-Response Relationship, Drug; Dou | 1993 |
EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence.
Topics: Adult; Affect; Alpha Rhythm; Caffeine; Central Nervous System Stimulants; Cotinine; Depressive Disor | 1999 |
Caffeine augmentation of ECT.
Topics: Adult; Aged; Caffeine; Depressive Disorder; Double-Blind Method; Electroconvulsive Therapy; Female; | 1990 |
Pharmacologic provocation and dexamethasone suppression test sensitivity.
Topics: Caffeine; Depressive Disorder; Dexamethasone; Electroconvulsive Therapy; Humans; Hydrocortisone; Lor | 1989 |
Caffeine-induced escape from dexamethasone suppression.
Topics: Adult; Caffeine; Clinical Trials as Topic; Coffee; Depressive Disorder; Dexamethasone; Dose-Response | 1985 |
47 other studies available for caffeine and Depression, Endogenous
| Article | Year |
|---|---|
A Case of Caffeine Intolerance With Long-Term Use of Fluoxetine.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Caffeine; Central Nervous System Stimulants; C | 2017 |
Whether caffeine use is a protective or a risk factor for depression and suicide?
Topics: Caffeine; Depressive Disorder; Humans; Protective Factors; Risk Factors; Suicide; Suicide Prevention | 2017 |
Energy drinks, caffeine, junk food, breakfast, depression and academic attainment of secondary school students.
Topics: Academic Success; Breakfast; Caffeine; Child; Cross-Sectional Studies; Depression; Depressive Disord | 2018 |
Sex and housing conditions modify the effects of adolescent caffeine exposure on anxiety-like and depressive-like behavior in the rat.
Topics: Age Factors; Animals; Anxiety; Anxiety Disorders; Behavior, Animal; Caffeine; Depression; Depressive | 2019 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress.
Topics: Analysis of Variance; Autonomic Nervous System; Brain Injuries; Caffeine; Confounding Factors, Epide | 2014 |
Adenosine signaling in reserpine-induced depression in rats.
Topics: Adenosine; Adrenergic Uptake Inhibitors; Animals; Brain; Caffeine; Depressive Disorder; Dose-Respons | 2015 |
Caffeine consumption and self-assessed stress, anxiety, and depression in secondary school children.
Topics: Adolescent; Anxiety; Anxiety Disorders; Caffeine; Carbonated Beverages; Child; Coffee; Cross-Section | 2015 |
Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine; Caffeine; Central Nervous Syst | 2010 |
Dose-dependent effects of caffeine on behavior and thermoregulation in a chronic unpredictable stress model of depression in rats.
Topics: Analysis of Variance; Animals; Anxiety; Behavior, Animal; Body Temperature Regulation; Caffeine; Cen | 2010 |
Coffee, tea and caffeine intake and the risk of severe depression in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Topics: Adult; Caffeine; Camellia sinensis; Coffee; Cohort Studies; Depressive Disorder; Finland; Humans; Ma | 2010 |
Coffee, caffeine, and risk of depression among women.
Topics: Adult; Aged; Caffeine; Central Nervous System Stimulants; Coffee; Depression; Depressive Disorder; F | 2011 |
Coffee consumption and depression risk: comment on "coffee, caffeine, and risk of depression among women".
Topics: Caffeine; Central Nervous System Stimulants; Coffee; Depression; Depressive Disorder; Female; Humans | 2011 |
Coffee or camaraderie?
Topics: Caffeine; Central Nervous System Stimulants; Coffee; Depression; Depressive Disorder; Female; Humans | 2012 |
Effect of long-term caffeine administration on depressive-like behavior in rats exposed to chronic unpredictable stress.
Topics: Administration, Oral; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Temperature; | 2012 |
Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
Topics: Adrenocorticotropic Hormone; Adult; Age Factors; Age of Onset; Antidepressive Agents; Caffeine; Cort | 2003 |
Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors.
Topics: Adenosine; Animals; Antidepressive Agents; Caffeine; Depressive Disorder; Disease Models, Animal; Fe | 2004 |
Excessive daytime sleepiness and subsequent development of Parkinson disease.
Topics: Aged; Aged, 80 and over; Aging; Brain; Caffeine; Causality; Cognition Disorders; Cohort Studies; Com | 2005 |
Effects of tianeptine on onset time of pentylenetetrazole-induced seizures in mice: possible role of adenosine A1 receptors.
Topics: Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Anticonvulsants; Antidep | 2007 |
Behavioural problems in children taking theophylline.
Topics: Adult; Asthma; Caffeine; Child; Child Behavior Disorders; Depressive Disorder; Female; Humans; Theop | 1984 |
CNS stimulants and the look-alike drugs.
Topics: Amphetamine; Caffeine; Central Nervous System Stimulants; Depressive Disorder; Ephedrine; Humans; Il | 1984 |
Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence.
Topics: Adult; Anxiety Disorders; Arousal; Caffeine; Coffee; Depressive Disorder; Fear; Female; Humans; Male | 1984 |
Safety and efficacy of caffeine-augmented ECT in elderly depressives: a retrospective study.
Topics: Aged; Blood Pressure; Caffeine; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Male | 1995 |
Supraventricular tachycardia in a patient receiving ECT, clozapine, and caffeine.
Topics: Affective Disorders, Psychotic; Aged; Caffeine; Clozapine; Combined Modality Therapy; Depressive Dis | 1994 |
Sertraline-induced stuttering.
Topics: 1-Naphthylamine; Caffeine; Depressive Disorder; Humans; Male; Middle Aged; Selective Serotonin Reupt | 1994 |
Complexity of adjunctive pharmacological agents in ECT.
Topics: Animals; Caffeine; Depressive Disorder; Electroconvulsive Therapy; Functional Laterality; Humans; Pr | 1994 |
Neurobiology of social phobia.
Topics: Animals; Caffeine; Depressive Disorder; Dexamethasone; Diagnosis, Differential; Dogs; Epinephrine; H | 1993 |
Caffeine withdrawal, metoclopramide, and depression.
Topics: Adult; Caffeine; Depressive Disorder; Drug Interactions; Humans; Male; Metoclopramide; Substance Wit | 1993 |
A reappraisal of the role of caffeine in ECT.
Topics: Brain; Caffeine; Depressive Disorder; Electroconvulsive Therapy; Electroencephalography; Female; Fun | 1993 |
Depressive symptoms and the self-reported use of alcohol, caffeine, and carbohydrates in normal volunteers and four groups of psychiatric outpatients.
Topics: Alcohol Drinking; Alcoholism; Ambulatory Care; Analysis of Variance; Caffeine; Coffee; Depression; D | 1993 |
Self-reported alcohol use patterns in a sample of male and female heavy smokers.
Topics: Adult; Alcohol Drinking; Alcoholic Beverages; Caffeine; Coffee; Comorbidity; Depressive Disorder; Fe | 1997 |
Oral caffeine augmentation of ECT.
Topics: Administration, Oral; Age Factors; Caffeine; Depressive Disorder; Electroconvulsive Therapy; Humans | 1992 |
Oral versus intravenous caffeine augmentation of ECT.
Topics: Administration, Oral; Aged; Caffeine; Depressive Disorder; Electroconvulsive Therapy; Humans; Inject | 1992 |
Olfactory hallucination after intravenous caffeine.
Topics: Caffeine; Depressive Disorder; Electroconvulsive Therapy; Female; Hallucinations; Humans; Injections | 1992 |
Dietary alteration of somatic symptoms and regional brain electrical activity.
Topics: Adult; Arousal; Brain Mapping; Caffeine; Cerebral Cortex; Depressive Disorder; Electroencephalograph | 1991 |
Validation of aversion towards open space and height as a measure of anxiety in the genetically based animal model of depression.
Topics: Animals; Anxiety; Behavior, Animal; Caffeine; Depressive Disorder; Diazepam; Disease Models, Animal; | 1990 |
Caffeine-modified electroconvulsive therapy in depressed patients with medical illness.
Topics: Aged; Aged, 80 and over; Caffeine; Cardiovascular Diseases; Depressive Disorder; Electroconvulsive T | 1990 |
Fluoxetine treatment of a depressed patient susceptible to malignant hyperthermia.
Topics: Adolescent; Caffeine; Depressive Disorder; Disease Susceptibility; Female; Fluoxetine; Halothane; Hu | 1989 |
The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia.
Topics: Adult; Alcohol Drinking; Anxiety Disorders; Caffeine; Cohort Studies; Conflict, Psychological; Depre | 1989 |
Adverse reaction to use of caffeine in ECT.
Topics: Benzoates; Caffeine; Depressive Disorder; Drug Combinations; Electroconvulsive Therapy; Humans; Hype | 1988 |
Anxiogenic effects of caffeine on panic and depressed patients.
Topics: Adult; Anxiety Disorders; Bipolar Disorder; Caffeine; Coffee; Depressive Disorder; Drinking; Fear; F | 1988 |
Chronic caffeine consumption and the dexamethasone suppression test in depression.
Topics: Adult; Aged; Aged, 80 and over; Caffeine; Depressive Disorder; Dexamethasone; Dose-Response Relation | 1988 |
Pharmacological manipulation of ECT-induced seizure duration.
Topics: Caffeine; Depressive Disorder; Differential Threshold; Electroconvulsive Therapy; Humans; Premedicat | 1986 |
Augmentation of ECT seizures with caffeine.
Topics: Aged; Aged, 80 and over; Caffeine; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; M | 1987 |
Use of caffeine to lengthen seizures in ECT.
Topics: Aged; Benzoates; Brain; Caffeine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Combin | 1987 |
Facilitation of ECT by caffeine pretreatment.
Topics: Benzoates; Blood Pressure; Brain; Caffeine; Depressive Disorder; Drug Combinations; Electroconvulsiv | 1987 |
Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness.
Topics: Adult; Agoraphobia; Alcoholism; Anxiety Disorders; Caffeine; Chronic Disease; Depressive Disorder; D | 1986 |
Dexamethasone suppression test.
Topics: Caffeine; Depressive Disorder; Dexamethasone; Humans; Hydrocortisone | 1986 |